Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the...
United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(14)
•••
drewmumaw
X
View Profile
View Bullboard History
Comment by
drewmumaw
on Oct 06, 2023 3:11pm
RE:Comprehensive Valuation Report on Cipheras of August 31 2023
Does management really believe that a lot of shareholders will tender their shares with that kind of growth ? I hope so. The overhead for this auction is costing the company $400k. From page 41:
...more
(3)
•••
stef1234
X
View Profile
View Bullboard History
Post by
stef1234
on Oct 03, 2023 10:00pm
Comprehensive Valuation Report on Cipheras of August 31 2023
A very interesting reading found in Issuer Bid Circular issued in September. You can find a Comprehensive valuation report on Cipher in the last 40 pages of the issuer bid circular made by Evans
...more
Stream Hatchet, a GameSquare Company, Announces Riot Games Renewal and Expansion
posted Jun 26, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Eduard Montserrat, CEO of Stream Hatchet, stated: "We are excited to renew and deepen our work with Riot Games. Our collaboration with Riot Games marks a significant milestone for Stream Hatchet and Sideqik as we benefit from the complementary nature of their combined offerings. This is the latest example of how our expanded data and analytic offerings support the world's leading ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 03, 2023 7:02am
New Press Release - Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid
MISSISSAUGA, ON, Oct. 3, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company"), today provided a reminder of its previously announced substantial issuer bid (the "Offer" or "SIB") under which the Company has offered to purchase for cancellation up to $6,000,000 of its...
read article.
(14)
•••
drewmumaw
X
View Profile
View Bullboard History
Comment by
drewmumaw
on Sep 26, 2023 5:07pm
RE:Cipher share price is ahead of Knight Therapeutics this a.m.
My initial reaction to the Dutch auction was that it was another way—in addition to the NCIB—to shake out paper hands before they make an acquisition that may lift the share price significantly higher
...more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Post by
PitchinPennies
on Sep 25, 2023 12:15pm
Cipher share price is ahead of Knight Therapeutics this a.m.
Cipher passed Knight? I have to admit I didn't see this happening -- ever. Probably reflects more on what Knight failed to accomplish with its great resources, and less on Craig Mull's having
...more
(2)
•••
ValueCat
X
View Profile
View Bullboard History
Post by
ValueCat
on Sep 21, 2023 1:20pm
Big bids
Trading massively above the range. bump on the way?
(5951)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Sep 18, 2023 1:23pm
Ink Research
Morning Report: Cipher Pharmaceuticals makes its mark in the INK Top 40 September 18, 2023 Cipher Pharmaceuticals (CPH) stock has been on a steady rise over the past year,
...more
(5951)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Sep 18, 2023 1:21pm
Ryan Irvine
He and his partner (Aaron Dunn) made their annual appearance at the Toronto MoneyShow on 8 Feb. For those who are unfamiliar with them, their firm (Keystone Financial) analyses over 4000
...more
(14)
•••
drewmumaw
X
View Profile
View Bullboard History
Comment by
drewmumaw
on Aug 29, 2023 4:38pm
RE:Adieu
Adieu Monsieur. I’ve appreciated your input over the years on this board. Hopefully, you come back in the future. I agree with your general overview regarding Cipher’s declining business. I continue
...more
(129)
•••
Northforce13
X
View Profile
View Bullboard History
Post by
Northforce13
on Aug 29, 2023 9:40am
Adieu
I bid you all "adieu" fellow CPH investors, it's been a fantastic fun ride :-) CPH remains a good stock at a decent price, but no longer a great bargain, so I have taken my winnings off
...more
(129)
•••
Northforce13
X
View Profile
View Bullboard History
Comment by
Northforce13
on Aug 07, 2023 11:10am
RE:RE:Cipher Partner, Moberg Pharma Announces Approval for MOB-015
The U.S. requires two phase 3 studies for approval. EU does not, if I remember correctly Moberg is taking advantage of the second phase 3 to try using a shorter treatment period, allowing more
...more
(14)
•••
drewmumaw
X
View Profile
View Bullboard History
Comment by
drewmumaw
on Jul 21, 2023 10:51am
RE:Cipher Partner, Moberg Pharma Announces Approval for MOB-015
I find it a bit odd that the nail whitening issue requires an additional phase 3 trial to gain approval in the US and Canada, but the European Union approved it regardless. The purpose of this
...more
(59)
•••
Daudau11
X
View Profile
View Bullboard History
Post by
Daudau11
on Jul 05, 2023 8:01am
Cipher Partner, Moberg Pharma Announces Approval for MOB-015
Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union T.CPH | 57 minutes ago Significant regulatory milestone
...more
(0)
•••
evenhand
X
View Profile
View Bullboard History
Comment by
evenhand
on Jul 04, 2023 1:06pm
RE:SCD Interview on YouTube
Almost the same story as in the run up of a few years back. "They are ready to grow". I have held some shares since then just to see if I can get some of my money back. A hobby
...more
(1)
•••
GJS471
X
View Profile
View Bullboard History
Comment by
GJS471
on Jul 01, 2023 11:49am
RE:RE:RE:RE:RE:CPH: Outperformer, Give Credit When Credit Is Due
The compensation numbers speak for them selves. As for the roles they play, I think they better start playing them soon. Here are the numbers for the Q1 report regarding compensation
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
How a truck transportation and logistics company leverages acquisitions and technology
High-grade gold potential in the world’s best mining jurisdiction
Uranium Explorer to Commence Drill Program at Clearwater West Project in Saskatchewan
Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets